1. Home
  2. YDESW vs WGSWW Comparison

YDESW vs WGSWW Comparison

Compare YDESW & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDESW

YD Bio Limited Warrants

N/A

Current Price

$1.15

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Logo GeneDx Holdings Corp.

WGSWW

GeneDx Holdings Corp.

N/A

Current Price

$0.05

Market Cap

0.0

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
YDESW
WGSWW
Founded
N/A
2017
Country
United States
United States
Employees
N/A
1000
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
YDESW
WGSWW
Price
$1.15
$0.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
36.6K
Earning Date
N/A
02-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$305,450,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
50.79
52 Week Low
N/A
$0.17
52 Week High
N/A
$0.21

Technical Indicators

Market Signals
Indicator
YDESW
WGSWW
Relative Strength Index (RSI) N/A 41.01
Support Level N/A $0.04
Resistance Level N/A $0.06
Average True Range (ATR) 0.00 0.01
MACD 0.00 0.00
Stochastic Oscillator 0.00 38.01

Price Performance

Historical Comparison
YDESW
WGSWW

About YDESW YD Bio Limited Warrants

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Share on Social Networks: